海外の治験の状況「1」での検索結果
1852件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
- Childhood Acute Lymphoblastic Leukemia;Childhood Rhabdomyosarcoma;Childhood Soft Tissue Sarcoma;Ewing Sarcoma;Ewing Sarcoma of Bone;Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET);Unspecified Childhood Solid Tumor, Protocol Specific;Wilms Tumor and Other Childhood Kidney Tumors;Childhood Acute Lymphoblastic Leukemia;Childhood Rhabdomyosarcoma;Childhood Soft Tissue Sarcoma;Ewing Sarcoma;Ewing Sarcoma of Bone;Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET);Unspecified Childhood Solid Tumor, Protocol Specific;Wilms Tumor and Other Childhood Kidney Tumors;Childhood Acute Lymphoblastic Leukemia;Childhood Rhabdomyosarcoma;Childhood Soft Tissue Sarcoma;Ewing Sarcoma;Ewing Sarcoma of Bone;Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET);Unspecified Childhood Solid Tumor, Protocol Specific;Wilms Tumor and Other Childhood Kidney Tumors;Childhood Acute Lymphoblastic Leukemia;Childhood Rhabdomyosarcoma;Childhood Soft Tissue Sarcoma;Ewing Sarcoma;Ewing Sarcoma of Bone;Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET);Unspecified Childhood Solid Tumor, Protocol Specific;Wilms Tumor and Other Childhood Kidney Tumors
- Australia, Canada, United States
- 2008-05-06
Not Recruiting
- A Controlled Study to Investigate the Effectiveness and Safety of TAK-875 Compared to Glimepiride When Used in Combination with Metformin in Individuals Diagnosed with Type 2 Diabetes
- Type 2 diabetes mellitus (T2DM) MedDRA version: 14.1 Level: LLT Classification code 10063624 Term: Type II diabetes mellitus inadequate control System Organ Class: 10027433 - Metabolism and nutrition disorders MedDRA version: 14.1 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders MedDRA version: 14.1 Level: LLT Classification code 10029505 Term: Non-insulin-dependent diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders MedDRA version: 14.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders MedDRA version: 14.1 Level: LLT Classification code 10012613 Term: Diabetes mellitus non-insulin-dependent System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Czech Republic, Estonia, Germany, Hong Kong, Israel, Latvia, Lithuania, Malaysia, Mexico, New Zealand, Philippines, Poland, Romania, Russian Federation, South Africa, Taiwan, Ukraine, United Kingdom, United States
- 2011-12-20
Not recruiting
- A Randomised Control Trial of the Flinders Model of Self-Management support for older Australians with complex chronic diseases, and their carers.
- Cardiovascular disease (including: ischaemic heart disease, cerebrovascular disease/stroke, peripheral vascular disease, congestive heart failure, hypertension).;Respiratory (including: asthma, chronic obstructive pulmonary disease).;Musculoskeletal (including: osteoarthritis, rheumatoid arthritis, other arthritis, osteoporosis, chronic back pain).;Psychological (including: depression, anxiety, insomnia).;Digestive (including: gastro-oesophageal reflux disease).;Kidney disease;Diabetes (Type 1 or Type 2).;Non-end stage cancers.
- Australia
- 2009-08-24
Not recruiting
- Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer
- Clear Cell Renal Cell Carcinoma;Recurrent Renal Cell Carcinoma;Stage IV Renal Cell Cancer;Type 1 Papillary Renal Cell Carcinoma;Type 2 Papillary Renal Cell Carcinoma;Clear Cell Renal Cell Carcinoma;Recurrent Renal Cell Carcinoma;Stage IV Renal Cell Cancer;Type 1 Papillary Renal Cell Carcinoma;Type 2 Papillary Renal Cell Carcinoma;Clear Cell Renal Cell Carcinoma;Recurrent Renal Cell Carcinoma;Stage IV Renal Cell Cancer;Type 1 Papillary Renal Cell Carcinoma;Type 2 Papillary Renal Cell Carcinoma;Clear Cell Renal Cell Carcinoma;Recurrent Renal Cell Carcinoma;Stage IV Renal Cell Cancer;Type 1 Papillary Renal Cell Carcinoma;Type 2 Papillary Renal Cell Carcinoma
- Australia, Korea, Democratic People's Republic of, Taiwan, United States
- 2012-11-12
Not recruiting
- Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
- Acute Lymphoblastic Leukemia;Adult B Lymphoblastic Lymphoma;Ann Arbor Stage I B Lymphoblastic Lymphoma;Ann Arbor Stage II B Lymphoblastic Lymphoma;Childhood B Acute Lymphoblastic Leukemia;Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1;Childhood B Lymphoblastic Lymphoma;Down Syndrome;Hypodiploid B Acute Lymphoblastic Leukemia;Intrachromosomal Amplification of Chromosome 21;Philadelphia Chromosome Positive;Untreated Adult Acute Lymphoblastic Leukemia;Untreated Childhood Acute Lymphoblastic Leukemia
- Australia, Canada, Ireland, New Zealand, Puerto Rico, Switzerland, United States
- 2010-08-27
Not Recruiting
- Magnetic Resonance Imaging (MRI) Biomarker Study: an observational study to assess differential changes that occur in the brains of participants with various neurodegenerative diseases using MRI technology.
- Alzheimer's disease [AD];Frontotemporal dementia [FTD] ;Parkinson's disease [PD] ;motor neuron disease [ALS] ;progressive supranuclear palsy [PSP] ;corticobasal degeneration [CBD];Dementia with Lewy Bodies ; Alzheimer's disease [AD] Frontotemporal dementia [FTD] Parkinson's disease [PD] motor neuron disease [ALS] progressive supranuclear palsy [PSP] corticobasal degeneration [CBD] Dementia with Lewy Bodies ;Neurological - Neurodegenerative diseases;Neurological - Alzheimer's disease;Neurological - Parkinson's disease;Neurological - Dementias
- Australia
- 2018-12-19
Not recruiting
- Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
- Adult Immunoblastic Lymphoma;Central Nervous System Non-Hodgkin Lymphoma;Childhood Immunoblastic Lymphoma;Grade 1 Follicular Lymphoma;Grade 2 Follicular Lymphoma;Grade 3 Follicular Lymphoma;Lymphoproliferative Disorder;Mantle Cell Lymphoma;Marginal Zone Lymphoma;Non-Hodgkin Lymphoma;Primary Cutaneous B-Cell Non-Hodgkin Lymphoma;Primary Cutaneous T-Cell Non-Hodgkin Lymphoma;Small Lymphocytic Lymphoma
- Australia, Canada, Puerto Rico, United States
- 2009-10-22
Not Recruiting
- Efficacy and safety of finerenone in subjects with chronic heart failure at high risk of recurrent heart failure decompensation
- Subjects with chronic heart failure and reduced ejection fraction after recent heart failure decompensation and additional risk factors, either type 2 diabetes mellitus or chronic kidney disease or both MedDRA version: 18.0 Level: LLT Classification code 10076410 Term: Chronic kidney disease stage 3 System Organ Class: 100000004857 MedDRA version: 18.0 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861 MedDRA version: 18.0 Level: LLT Classification code 10066498 Term: Cardiac failure chronic aggravated System Organ Class: 100000004849 MedDRA version: 18.0 Level: LLT Classification code 10076408 Term: Chronic kidney disease stage 1 System Organ Class: 100000004857 MedDRA version: 18.0 Level: LLT Classification code 10076409 Term: Chronic kidney disease stage 2 System Organ Class: 100000004857 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States, Vietnam
- 2015-09-04
Not Recruiting
- Efficacy and safety of finerenone in subjects with chronic heart failure at high risk of recurrent heart failure decompensation
- Subjects with chronic heart failure and reduced ejection fraction after recent heart failure decompensation and additional risk factors, either type 2 diabetes mellitus or chronic kidney disease or both MedDRA version: 18.1 Level: LLT Classification code 10076410 Term: Chronic kidney disease stage 3 System Organ Class: 100000004857 MedDRA version: 18.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861 MedDRA version: 18.1 Level: LLT Classification code 10066498 Term: Cardiac failure chronic aggravated System Organ Class: 100000004849 MedDRA version: 18.1 Level: LLT Classification code 10076408 Term: Chronic kidney disease stage 1 System Organ Class: 100000004857 MedDRA version: 18.1 Level: LLT Classification code 10076409 Term: Chronic kidney disease stage 2 System Organ Class: 100000004857 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States, Vietnam
- 2015-09-09
Not recruiting
- Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
- Recurrent Childhood Brain Stem Glioma;Recurrent Childhood Cerebellar Astrocytoma;Recurrent Childhood Cerebral Astrocytoma;Recurrent Childhood Ependymoma;Recurrent Childhood Large Cell Lymphoma;Recurrent Childhood Liver Cancer;Recurrent Childhood Lymphoblastic Lymphoma;Recurrent Childhood Malignant Germ Cell Tumor;Recurrent Childhood Medulloblastoma;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Small Noncleaved Cell Lymphoma;Recurrent Childhood Soft Tissue Sarcoma;Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;Recurrent Childhood Visual Pathway and Hypothalamic Glioma;Recurrent Childhood Visual Pathway Glioma;Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;Recurrent Neuroblastoma;Recurrent Osteosarcoma;Recurrent Retinoblastoma;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Recurrent/Refractory Childhood Hodgkin Lymphoma;Unspecified Childhood Solid Tumor, Protocol Specific
- Australia, Canada, United States
- 2001-03-03
Not recruiting
- Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction
- Adult Grade III Lymphomatoid Granulomatosis;Adult Nasal Type Extranodal NK/T-cell Lymphoma;Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;Nodal Marginal Zone B-cell Lymphoma;Recurrent Adult Burkitt Lymphoma;Recurrent Adult Diffuse Large Cell Lymphoma;Recurrent Adult Diffuse Mixed Cell Lymphoma;Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;Recurrent Adult Grade III Lymphomatoid Granulomatosis;Recurrent Adult Immunoblastic Large Cell Lymphoma;Recurrent Adult Lymphoblastic Lymphoma;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Grade 3 Follicular Lymphoma;Recurrent Mantle Cell Lymphoma;Recurrent Marginal Zone Lymphoma;Recurrent Small Lymphocytic Lymphoma;Refractory Multiple Myeloma;Splenic Marginal Zone Lymphoma;Stage III Multiple Myeloma;Stage IV Adult Burkitt Lymphoma;Stage IV Adult Diffuse Large Cell Lymphoma;Stage IV Adult Diffuse Mixed Cell Lymphoma;Stage IV Adult Diffuse Small Cleaved Cell Lymphoma;Stage IV Adult Immunoblastic Large Cell Lymphoma;Stage IV Adult Lymphoblastic Lymphoma;Stage IV Grade 1 Follicular Lymphoma;Stage IV Grade 2 Follicular Lymphoma;Stage IV Grade 3 Follicular Lymphoma;Stage IV Mantle Cell Lymphoma;Stage IV Marginal Zone Lymphoma;Stage IV Small Lymphocytic Lymphoma;Unspecified Adult Solid Tumor, Protocol Specific;Waldenström Macroglobulinemia
- Australia, United States
- 2003-02-05
Not recruiting
- Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
- Childhood Acute Lymphoblastic Leukemia in Remission;Childhood Acute Myeloid Leukemia in Remission;Childhood Chronic Myelogenous Leukemia;Childhood Myelodysplastic Syndromes;Chronic Eosinophilic Leukemia;Chronic Myelomonocytic Leukemia;Chronic Neutrophilic Leukemia;de Novo Myelodysplastic Syndromes;Disseminated Neuroblastoma;Juvenile Myelomonocytic Leukemia;Mucositis;Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;Previously Treated Childhood Rhabdomyosarcoma;Previously Treated Myelodysplastic Syndromes;Recurrent Childhood Acute Lymphoblastic Leukemia;Recurrent Childhood Acute Myeloid Leukemia;Recurrent Childhood Large Cell Lymphoma;Recurrent Childhood Lymphoblastic Lymphoma;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Small Noncleaved Cell Lymphoma;Recurrent Malignant Testicular Germ Cell Tumor;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Recurrent/Refractory Childhood Hodgkin Lymphoma;Relapsing Chronic Myelogenous Leukemia;Secondary Acute Myeloid Leukemia;Secondary Myelodysplastic Syndromes;Unspecified Childhood Solid Tumor, Protocol Specific;Childhood Acute Lymphoblastic Leukemia in Remission;Childhood Acute Myeloid Leukemia in Remission;Childhood Chronic Myelogenous Leukemia;Childhood Myelodysplastic Syndromes;Chronic Eosinophilic Leukemia;Chronic Myelomonocytic Leukemia;Chronic Neutrophilic Leukemia;de Novo Myelodysplastic Syndromes;Disseminated Neuroblastoma;Juvenile Myelomonocytic Leukemia;Mucositis;Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;Previously Treated Childhood Rhabdomyosarcoma;Previously Treated Myelodysplastic Syndromes;Recurrent Childhood Acute Lymphoblastic Leukemia;Recurrent Childhood Acute Myeloid Leukemia;Recurrent Childhood Large Cell Lymphoma;Recurrent Childhood Lymphoblastic Lymphoma;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Small Noncleaved Cell Lymphoma;Recurrent Malignant Testicular Germ Cell Tumor;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Recurrent/Refractory Childhood Hodgkin Lymphoma;Relapsing Chronic Myelogenous Leukemia;Secondary Acute Myeloid Leukemia;Secondary Myelodysplastic Syndromes;Unspecified Childhood Solid Tumor, Protocol Specific;Childhood Acute Lymphoblastic Leukemia in Remission;Childhood Acute Myeloid Leukemia in Remission;Childhood Chronic Myelogenous Leukemia;Childhood Myelodysplastic Syndromes;Chronic Eosinophilic Leukemia;Chronic Myelomonocytic Leukemia;Chronic Neutrophilic Leukemia;de Novo Myelodysplastic Syndromes;Disseminated Neuroblastoma;Juvenile Myelomonocytic Leukemia;Mucositis;Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;Previously Treated Childhood Rhabdomyosarcoma;Previously Treated Myelodysplastic Syndromes;Recurrent Childhood Acute Lymphoblastic Leukemia;Recurrent Childhood Acute Myeloid Leukemia;Recurrent Childhood Large Cell Lymphoma;Recurrent Childhood Lymphoblastic Lymphoma;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Small Noncleaved Cell Lymphoma;Recurrent Malignant Testicular Germ Cell Tumor;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Recurrent/Refractory Childhood Hodgkin Lymphoma;Relapsing Chronic Myelogenous Leukemia;Secondary Acute Myeloid Leukemia;Secondary Myelodysplastic Syndromes;Unspecified Childhood Solid Tumor, Protocol Specific;Childhood Acute Lymphoblastic Leukemia in Remission;Childhood Acute Myeloid Leukemia in Remission;Childhood Chronic Myelogenous Leukemia;Childhood Myelodysplastic Syndromes;Chronic Eosinophilic Leukemia;Chronic Myelomonocytic Leukemia;Chronic Neutrophilic Leukemia;de Novo Myelodysplastic Syndromes;Disseminated Neuroblastoma;Juvenile Myelomonocytic Leukemia;Mucositis;Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;Previously Treated Childhood Rhabdomyosarcoma;Previously Treated Myelodysplastic Syndromes;Recurrent Childhood Acute Lymphoblastic Leukemia;Recurrent Childhood Acute Myeloid Leukemia;Recurrent Childhood Large Cell Lymphoma;Recurrent Childhood Lymphoblastic Lymphoma;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Small Noncleaved Cell Lymphoma;Recurrent Malignant Testicular Germ Cell Tumor;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Recurrent/Refractory Childhood Hodgkin Lymphoma;Relapsing Chronic Myelogenous Leukemia;Secondary Acute Myeloid Leukemia;Secondary Myelodysplastic Syndromes;Unspecified Childhood Solid Tumor, Protocol Specific
- Australia, Canada, United States
- 2011-02-25
